Yu-Lin Lee

2.0k total citations
62 papers, 1.1k citations indexed

About

Yu-Lin Lee is a scholar working on Epidemiology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Yu-Lin Lee has authored 62 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 19 papers in Infectious Diseases and 19 papers in Molecular Medicine. Recurrent topics in Yu-Lin Lee's work include Antibiotic Resistance in Bacteria (19 papers), Infections and bacterial resistance (9 papers) and Bacterial Identification and Susceptibility Testing (9 papers). Yu-Lin Lee is often cited by papers focused on Antibiotic Resistance in Bacteria (19 papers), Infections and bacterial resistance (9 papers) and Bacterial Identification and Susceptibility Testing (9 papers). Yu-Lin Lee collaborates with scholars based in Taiwan, China and United States. Yu-Lin Lee's co-authors include Po‐Ren Hsueh, Wen‐Chien Ko, Liann‐Be Chang, Ming‐Jer Jeng, Chun-Eng Liu, Chun-Eng Liu, Yao-Shen Chen, Yen‐Hsu Chen, Yung-Ching Liu and Po‐Liang Lu and has published in prestigious journals such as PLoS ONE, Nutrients and Journal of Physics D Applied Physics.

In The Last Decade

Yu-Lin Lee

59 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu-Lin Lee Taiwan	18	390	368	244	172	168	62	1.1k
Dokyun Kim South Korea	20	340 0.9×	522 1.4×	244 1.0×	178 1.0×	176 1.0×	81	1.2k
J.-J. Wu Taiwan	22	315 0.8×	349 0.9×	262 1.1×	394 2.3×	50 0.3×	43	1.2k
Myrto Christofidou Greece	18	342 0.9×	411 1.1×	221 0.9×	124 0.7×	210 1.3×	40	836
Mansour Sedighi Iran	16	269 0.7×	259 0.7×	145 0.6×	154 0.9×	59 0.4×	40	1.1k
Alessandro Leonildi Italy	23	556 1.4×	1.2k 3.2×	242 1.0×	220 1.3×	474 2.8×	47	1.7k
Ching‐Tai Huang Taiwan	23	451 1.2×	196 0.5×	262 1.1×	87 0.5×	99 0.6×	73	1.6k
Hyuck Lee South Korea	18	420 1.1×	249 0.7×	233 1.0×	92 0.5×	109 0.6×	44	941
Lemonia Skoura Greece	17	301 0.8×	291 0.8×	282 1.2×	115 0.7×	85 0.5×	114	1.1k
Nenad Maćešić Australia	17	275 0.7×	577 1.6×	205 0.8×	178 1.0×	131 0.8×	41	1.0k
Sointu Mero Finland	16	225 0.6×	277 0.8×	334 1.4×	178 1.0×	94 0.6×	28	893

Countries citing papers authored by Yu-Lin Lee

Since Specialization

Citations

This map shows the geographic impact of Yu-Lin Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu-Lin Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu-Lin Lee more than expected).

Fields of papers citing papers by Yu-Lin Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu-Lin Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu-Lin Lee. The network helps show where Yu-Lin Lee may publish in the future.

Co-authorship network of co-authors of Yu-Lin Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Yu-Lin Lee. A scholar is included among the top collaborators of Yu-Lin Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu-Lin Lee. Yu-Lin Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yanru, Yu-Lin Lee, I‐Wen Huang, et al.. (2025). Susceptibilities of cefiderocol, meropenem-xeruborbactam, cefepime-taniborbactam, aztreonam-avibactam, and sulbactam-durlobactam against imipenem-non-susceptible Gram-negative bacilli in Taiwan. International Journal of Infectious Diseases. 163. 108279–108279.

Lee, Yu-Lin, Yih‐Ru Shiau, Huiying Wang, et al.. (2025). In vitro activity of cefepime-zidebactam, ceftolozane-tazobactam, ceftazidime-avibactam, imipenem-relebactam, and other comparators against imipenem-non-susceptible Pseudomonas aeruginosa in Taiwan, 2022. International Journal of Antimicrobial Agents. 66(3). 107550–107550. 1 indexed citations

Lee, Yu-Lin, Chun-Eng Liu, Yih‐Ru Shiau, et al.. (2025). Antimicrobial resistance among imipenem-non-susceptible Escherichia coli and Klebsiella pneumoniae isolates, with an emphasis on novel β-lactam/β-lactamase inhibitor combinations and tetracycline derivatives: The Taiwan surveillance of antimicrobial resistance program, 2020–2022. Journal of Microbiology Immunology and Infection. 58(2). 219–225. 3 indexed citations

Lee, Yu-Lin, Wei‐Yao Wang, Wen‐Chien Ko, & Po‐Ren Hsueh. (2024). Global epidemiology and antimicrobial resistance of Enterobacterales harbouring genes encoding OXA-48-like carbapenemases: insights from the results of the Antimicrobial Testing Leadership and Surveillance (ATLAS) programme 2018–2021. Journal of Antimicrobial Chemotherapy. 79(7). 1581–1589. 11 indexed citations

Yang, Ya‐Sung, Yu-Lin Lee, Yuag-Meng Liu, et al.. (2024). Acquired blaCfxA-3 carried by a conjugative transposon or duplicated intrinsic blaCME-3 mediates cefiderocol resistance in Elizabethkingia anophelis clinical isolates. International Journal of Antimicrobial Agents. 64(6). 107378–107378.

Lee, Yu-Lin, Chun-Eng Liu, Hung-Jen Tang, et al.. (2024). Epidemiology and antimicrobial susceptibility profiles of Enterobacterales causing bloodstream infections before and during COVID-19 pandemic: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2018–2021. Journal of Microbiology Immunology and Infection. 57(3). 446–456. 4 indexed citations

Lee, Yu-Lin, Chun-Eng Liu, Wen‐Chien Ko, & Po‐Ren Hsueh. (2023). In vitro susceptibilities of Stenotrophomonas maltophilia isolates to antimicrobial agents commonly used for related infections: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2004-2020. International Journal of Antimicrobial Agents. 62(2). 106878–106878. 7 indexed citations

Lee, Yu-Lin, Wen‐Chien Ko, & Po‐Ren Hsueh. (2023). In vitro activities of ceftazidime–avibactam, ceftolozane–tazobactam, meropenem–vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012–2021. International Journal of Antimicrobial Agents. 62(2). 106867–106867. 9 indexed citations

Su, Wei‐Wen, Chih‐Chao Yang, Yung‐Hsiang Yeh, et al.. (2023). A new collaborative care approach toward hepatitis C elimination in marginalized populations. Journal of Infection and Public Health. 16(8). 1201–1208. 6 indexed citations

10.

Jean, Shio-Shin, Yu-Lin Lee, Chin‐Wang Hsu, & Po‐Ren Hsueh. (2022). In vitro susceptibilities of isolates of potentially naturally inducible chromosomal AmpC-producing metallo-β-lactamase-negative carbapenem-resistant Enterobacterales species to ceftazidime-avibactam: Data from the Antimicrobial Testing Leadership and Surveillance Programme, 2012–2019. International Journal of Antimicrobial Agents. 60(3). 106617–106617. 2 indexed citations

11.

Lee, Yu-Lin, Wen‐Chien Ko, & Po‐Ren Hsueh. (2022). Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime/avibactam, meropenem/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020. International Journal of Antimicrobial Agents. 60(5-6). 106679–106679. 24 indexed citations

12.

Lee, Yu-Lin, et al.. (2022). Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment. International Journal of Antimicrobial Agents. 59(2). 106528–106528. 48 indexed citations

13.

Lee, Yu-Lin, Wen‐Chien Ko, & Po‐Ren Hsueh. (2022). In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Enterobacterales from patients with intra-abdominal infections: Results of the study for Monitoring Antimicrobial Resistance Trends (SMART) in Taiwan, 2020. Journal of Microbiology Immunology and Infection. 56(1). 75–83. 5 indexed citations

14.

Lee, Yu-Lin, Wen‐Chien Ko, & Po‐Ren Hsueh. (2022). Geographic patterns of Acinetobacter baumannii and carbapenem resistance in the Asia-Pacific Region: results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2019. International Journal of Infectious Diseases. 127. 48–55. 31 indexed citations

15.

Liu, Chun-Eng, et al.. (2022). Seroprevalence of varicella-zoster virus antibody and immunogenicity of live attenuated varicella vaccine in healthcare workers in Taiwan. Journal of Microbiology Immunology and Infection. 56(2). 274–281. 6 indexed citations

16.

Lin, Yi‐Chun, Yu-Lin Lee, Chien‐Yu Cheng, et al.. (2021). Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan. Journal of Microbiology Immunology and Infection. 54(5). 816–829. 8 indexed citations

17.

Jean, Shio-Shin, Yu-Lin Lee, Min‐Chi Lu, et al.. (2021). Bacteriophages and phage-delivered CRISPR-Cas system as antibacterial therapy. International Journal of Antimicrobial Agents. 59(1). 106475–106475. 25 indexed citations

18.

Lee, Yu-Lin, Kuan‐Yin Lin, Chien‐Yu Cheng, et al.. (2017). Evolution of hepatitis A virus seroprevalence among HIV-positive adults in Taiwan. PLoS ONE. 12(10). e0186338–e0186338. 14 indexed citations

19.

Lee, Yu-Lin, Chun-Eng Liu, Wen-Long Cho, et al.. (2014). Presence of cytomegalovirus DNA in leucocytes is associated with increased oxidative stress and subclinical atherosclerosis in healthy adults. Biomarkers. 19(2). 109–113. 25 indexed citations

20.

Lu, Po‐Liang, Yung-Ching Liu, Han Siong Toh, et al.. (2012). Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009–2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). International Journal of Antimicrobial Agents. 40. S37–S43. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact